Let's talk medical research

We’re thrilled to share that our CEO, Laurent Schockmel, has been named a top 40 Healthcare Transformer by Medical Marketing & Media (MM&M). ...

At Antidote, we talk a lot about how our search tool makes it easier to match with clinical trials you may qualify for. But what happens after you ...

Antidote recently conducted a survey with SCORR Marketing through which we asked nearly 4,000 patients about their perspectives on clinical trials. ...

With medicine getting ever more targeted and precise, clinical trial protocols are becoming more complex than ever before. While this allows for ...

During a Q3 2018 survey conducted by Antidote Technologies and SCORR Marketing, we explored specific participation stimuli to determine what could ...

There are conferences we attend to connect with clients. There are conferences we attend to build partnerships. At SCOPE, we are able to do both. The ...

Pulmonary hypertension (PH) is a type of high blood pressure in the lungs. A rare disease, PH is often misdiagnosed as asthma or COPD. Unfortunately, ...

Despite decades of research, heart disease continues to be the leading cause of death for both men and women in the United States. It’s clear that ...

At Antidote, our goal is to empower patients to connect with research and seek out the best treatments while learning more about their condition. ...

Hemophilia is a rare genetic bleeding disorder, affecting around 20,000 people in the U.S. Most cases of hemophilia are inherited, but for about 30% ...